About: Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 October 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в жовтні 2006 (uk) im Oktober 2006 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 12 October 2006 (en) 2006 թվականի հոկտեմբերի 12-ին հրատարակված գիտական հոդված (hy) artículu científicu espublizáu n'ochobre de 2006 (ast)
publication date	wds:Q79258362-F210EB35-D4A2-4D05-99D2-B1BBECF55A3F
publication date	2006-10-12 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q79258362-4108B33E-450E-481A-A82A-B74ABF8B4130
language of work or name	English
cites work	wds:Q79258362-0D05CDCF-18A4-4490-A80B-26143665D924 wds:Q79258362-0DC1B46E-D74E-4412-BB00-AF523C1BA4A5 wds:Q79258362-27964D95-70AE-4F2F-94BD-A549AB9F49FB wds:Q79258362-386D4795-1815-45C8-8E91-8F60918EC54F wds:Q79258362-3C12964E-ED68-49DD-B11B-22679CFEEC56 wds:Q79258362-4FA7B5E2-F6C0-4836-8679-16F98600EF3A wds:Q79258362-52153497-2F8A-4891-93E7-AD5275DF30D9 wds:Q79258362-523B385B-389A-4C59-9F2D-C4001403FF72 wds:Q79258362-52D93F5D-520C-4AF6-B925-9604314802C0 wds:Q79258362-592D6A7D-BBC0-4FED-BDF9-CCA1AFCE59E1 wds:Q79258362-5A6BA592-7F58-4390-ACF2-1563FD958DFC wds:Q79258362-5A91BFCA-11ED-419B-BAEE-28730FF4A00C wds:Q79258362-6327DB06-70AA-4933-B47A-A1A617F002D5 wds:Q79258362-65C6FC55-DC87-4C98-AE45-3A7C6EFB6B42 wds:Q79258362-678B94C7-6E1D-4680-8E95-8EDF13CD2EFD wds:Q79258362-707BFAFE-5224-4482-810A-30BA1F2C9BAC wds:Q79258362-72F06E35-A13C-42F6-8E89-3E901BF37310 wds:Q79258362-82BC9A74-3C04-46EB-A009-E9FB57E3F61A wds:Q79258362-848D905C-959B-4E8B-AC58-1AD76EE49BE5 wds:Q79258362-893588CD-06B2-4E40-ACDB-9AADBD87D3E2 wds:Q79258362-8FB855E4-875F-4CD5-B25A-AF2257283AD5 wds:Q79258362-A08A5488-3E43-4281-9D06-A91EA13F218C wds:Q79258362-A57A53D0-3A21-4531-A8FA-22A0CBF6E9E9 wds:Q79258362-ACD18939-C697-4717-BE20-BE6F6ECE312F wds:Q79258362-B27D496E-5EB5-4041-B108-9A2B6924F856 wds:Q79258362-BC4749A1-D825-442E-9CED-728E2393572E wds:Q79258362-C262F4A8-A407-4EC8-A6B2-48B75A528073 wds:Q79258362-C42CAE9F-48E8-4557-BC41-45331AA4CD15 wds:Q79258362-CEFDC555-BDF2-4EB9-8490-501CB77985AA wds:Q79258362-CF5AB64A-C644-485E-9317-7BD501E2A52B wds:Q79258362-DC1695AA-A160-4DCB-B189-AFBEC54DD2B6 wds:Q79258362-DDC47B80-3F34-485E-98E3-E385093A2A5D wds:Q79258362-E465A159-FD7B-4960-B31F-4D75F29AC9B0 wds:Q79258362-F6D6EDEF-1A03-4AF1-ACA9-71F648309424 wds:Q79258362-F7686A12-E72E-47E2-87B3-58CDFD5FD772 wds:Q79258362-F87CDD0A-9D30-4E67-BDA0-B6455303CA93 wds:Q79258362-FC93DB9B-5732-4ED1-83E1-AB37C8E0F87B wds:Q79258362-FCD9AAE3-F3DB-4D36-A44F-1EA5FE5BB9EF
cites work	A cluster of cases of severe acute respiratory syndrome in Hong Kong. Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism Small molecules targeting severe acute respiratory syndrome human coronavirus The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Characterization of a novel coronavirus associated with severe acute respiratory syndrome Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage The Genome sequence of the SARS-associated coronavirus Aetiology: Koch's postulates fulfilled for SARS virus Effects of chronic quercetin treatment in experimental renovascular hypertension A major outbreak of severe acute respiratory syndrome in Hong Kong Identification of severe acute respiratory syndrome in Canada Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations Severe acute respiratory syndrome: identification of the etiological agent Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate Mechanism of the maturation process of SARS-CoV 3CL protease High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. "Teaching old drugs to kill new bugs": structure-based discovery of anti-SARS drugs Synthesis of Novel 3,7-Substituted-2-(3‘,4‘-dihydroxyphenyl)flavones with Improved Antioxidant Activity Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase. Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease [Isolation of hyperoside (quercetin-3-D-galactoside) from Rumex acetosa] Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus Quercetin, a bioflavonoid, attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats
author name string	wds:Q79258362-012ECED1-84FD-4A57-BF39-917D7FB083C2 wds:Q79258362-2348B355-B068-4996-B54A-19DE90CB2C2A wds:Q79258362-49B596D5-5849-4185-9B95-B6D79419A6FF wds:Q79258362-5AD0622B-224C-40CB-BF32-C971A0EF8C16 wds:Q79258362-7EBA9C2E-A9E0-4E2A-BE14-F67564B0C18F wds:Q79258362-8F7B7999-1F71-4872-9D2D-EBB3B449E7FB wds:Q79258362-9331353C-5152-4D7C-90A1-11BF6A9C6486 wds:Q79258362-A70334AF-5147-4983-847A-1BF5699CB376 wds:Q79258362-F0069FE9-5741-4C75-A332-FD1F817DFDC1
author name string	Lili Chen Hong Liu Gang Chen

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software